[ 1 ] Klassen TP, Jadad AR, Moher D. Guides for reading and interpreting systematic reviews: I. Getting started[J]. Arch Pediatr Adolesc Med, 1998, 152(7): 700-704.
[2]
[ 2 ] Davidoff F, Haynes B, Sackett D, et al. Evidence-based medicine: a new journal to help doctors identify the information they need[J]. BMJ, 1995(310): 1085-1088.
[3]
[ 3 ] Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials[J]. BMJ, 2010(340): c332.
[4]
[ 4 ] Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial[J]. BMJ, 2010(340): c869.
[5]
[ 5 ] Wang G, Mao Bing, Xiong ZY, et al. The quality of reporting of randomized controlled trails of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China[J]. Clinl Ther, 2007, 29(7): 1456-1467.
[6]
[ 6 ] Wu TX, Li YP, Bian ZX, et al. Randomized trials published in some Chinese journals: how many are randomized [J]. Trials, 2009, 10: 46.
[7]
[ 7 ] Turner L, Shamseer L, Altman DG, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals[J]. Cochrane Database Syst Rev, 2012, 11: MR000030.
[8]
[ 8 ] He J, Du L, Liu G, et al. Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews[J]. Trials, 2011, 12: 122.
[9]
[ 9 ] Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. Ann Intern Med, 2009, 151(4): 264-269.
Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction[J]. JAMA, 1992, 268(2): 240-248.
[15]
Campbell J, Campbell S, Woodward G. Getting evidence into practice using an asthma desktop tool[J]. Aust Fam Physician, 2006, 35(1-2): 32-33.
National Center for the Dissemination of Disability Research. What is Knowledge Translation [EB/OL]. (2005-06-13)[2013-10-01]. http://www.ktdrr.org/ktlibrary/articles_pubs/ncddrwork/focus/focus10/Focus10.pdf.
[19]
National Center for the Dissemination of Disability Research. How is Knowledge Translation Defined[EB/OL]. [2013-12-05]. http://www.ncddr.org/kt/ktdefined.html.
[20]
Boissel JP, Amsallem E, Cucherat M, et al. Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation[J]. Eur J Clin Pharmacol, 2004, 60(9): 609-616.
[21]
Kendall S. Summaries of evidence: an adjunct to knowledge translation [J]. Prim Health Care Res Dev, 2013, 14(2): 107-108.
[22]
Canadian Institutes of Health Research. About knowledge translation & commercialization[EB/OL]. (2013-05-15)[2013-10-01]. http://www.cihr-irsc.gc.ca/e/29418.html.
[23]
Choi BC. Understanding the basic principles of knowledge translation[J]. J Epidemiol Community Health, 2005, 59(2): 93.
[24]
Logan J, Harrison MB, Graham ID, et al. Evidence-based pressure-ulcer practice: the Ottawa model of research use[J]. Can J Nurs Res, 1999, 31(1): 37-52.
[25]
Commission on Health Research for Development. Health research: essential link to equity in development[M]. New York: Oxford University Press, 1990.
[26]
Santesso N, Tugwell P. Knowledge translation in developing countries[J]. J Contin Educ Health Prof, 2006, 26(1): 87-96.
[27]
Chinnock P, Siegfried N, Clarke M. Is evidence-based medicine relevant to the developing world: Systematic reviews have yet to achieve their potential as a resource for practitioners in developing countries[J]. PLoS Med, 2005, 2(3): 321-324.
